Bemis Company, Inc. (NYSE:BMS) has received a consensus recommendation of “Hold” from the fifteen research firms that are covering the stock, Marketbeat.com reports. Three analysts have rated the stock with a sell recommendation, eight have given a hold recommendation and three have given a buy recommendation to the company. The average 12 month price objective among brokerages that have covered the stock in the last year is $49.44.
BMS has been the subject of a number of analyst reports. KeyCorp restated a “hold” rating on shares of Bemis in a research report on Friday, October 13th. Barclays raised their target price on Bemis from $50.00 to $52.00 and gave the stock an “overweight” rating in a research note on Monday, October 30th. Zacks Investment Research cut Bemis from a “hold” rating to a “sell” rating in a research note on Tuesday, December 26th. Finally, TheStreet raised Bemis from a “c+” rating to a “b-” rating in a research note on Wednesday, December 13th.
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in BMS. State Street Corp grew its stake in Bemis by 1.7% in the second quarter. State Street Corp now owns 6,345,626 shares of the industrial products company’s stock valued at $293,486,000 after acquiring an additional 104,558 shares during the period. Bank of New York Mellon Corp grew its stake in Bemis by 5.6% in the third quarter. Bank of New York Mellon Corp now owns 1,249,152 shares of the industrial products company’s stock valued at $56,923,000 after acquiring an additional 65,782 shares during the period. Dimensional Fund Advisors LP grew its stake in Bemis by 1.8% in the third quarter. Dimensional Fund Advisors LP now owns 1,201,776 shares of the industrial products company’s stock valued at $54,763,000 after acquiring an additional 21,541 shares during the period. Ameriprise Financial Inc. grew its stake in Bemis by 28.9% in the third quarter. Ameriprise Financial Inc. now owns 632,205 shares of the industrial products company’s stock valued at $28,807,000 after acquiring an additional 141,746 shares during the period. Finally, Epoch Investment Partners Inc. grew its stake in Bemis by 63.6% in the second quarter. Epoch Investment Partners Inc. now owns 552,534 shares of the industrial products company’s stock valued at $25,555,000 after acquiring an additional 214,801 shares during the period. 75.82% of the stock is owned by institutional investors and hedge funds.
Bemis (NYSE:BMS) last issued its quarterly earnings data on Thursday, October 26th. The industrial products company reported $0.70 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.65 by $0.05. Bemis had a return on equity of 17.83% and a net margin of 4.84%. The company had revenue of $1.04 billion during the quarter, compared to the consensus estimate of $1.02 billion. During the same period last year, the company earned $0.75 earnings per share. The firm’s revenue was up .8% compared to the same quarter last year. research analysts predict that Bemis will post 2.37 EPS for the current fiscal year.
TRADEMARK VIOLATION WARNING: This piece of content was posted by American Banking News and is the property of of American Banking News. If you are accessing this piece of content on another publication, it was stolen and republished in violation of US & international copyright & trademark legislation. The correct version of this piece of content can be viewed at https://www.americanbankingnews.com/2018/01/19/bemis-company-inc-bms-receives-consensus-rating-of-hold-from-analysts.html.
Bemis Company Profile
Bemis Company, Inc is a manufacturer of packaging products. The Company operates through two segments: U.S. Packaging and Global Packaging. The U.S. Packaging segment represents all food, consumer, and industrial products packaging-related manufacturing operations located in the United States. The Global Packaging segment includes all packaging-related manufacturing operations located outside of the United States, as well as global medical device and pharmaceutical packaging-related manufacturing operations.
Receive News & Ratings for Bemis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bemis and related companies with MarketBeat.com's FREE daily email newsletter.